Biohaven Insider Trades

BHVN

Track insider trading activity from Biohaven executives and directors. See which insiders are buying and selling BHVN stock.

Trades Last 12 Months

BHVN Price

All Insider Trades for Biohaven

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Hugin Robert J Director
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Childs John W Director
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Bailey Gregory Director
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Mehta Kishan Director
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Gregory Julia P Director
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Holding Value $743k 68,693 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 68,693 shares
$9.61
$10.81
Coric Vlad Chief Executive Officer
Holding Value $5.95M 550,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.34M 550,000 shares
$11.52
$10.81
Gentile Kimberly Svp, Clinical Operations
Holding Value $1.89M 175,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 175,000 shares
$11.52
$10.81
Buten Matthew Chief Financial Officer
Holding Value $1.89M 175,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 175,000 shares
$11.52
$10.81
Car Bruce Chief Scientific Officer
Holding Value $1.89M 175,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.02M 175,000 shares
$11.52
$10.81
Clark George C. Vp, Chief Accounting Officer
Holding Value $541k 50,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$576k 50,000 shares
$11.52
$10.81
Tilton John Director, Chief Commercial Officer
Holding Value $17.4k 1,614 shares
Last Trade
Oct 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$753k 5,068 shares
$148.50
$10.81
Holding Value $387M 35,839,857 shares
Last Trade
Oct 03, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$5.44B 35,839,857 shares
$151.80
$10.81
Conway Charles Director, Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Oct 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.29M 41,432 shares
$151.80
$10.81
Engelhart James Director, Strategic Advisor
Holding Value $0 0 shares
Last Trade
Oct 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.19M 27,602 shares
$151.80
$10.81
Jones William A Jr Director, Cco-migraine & Common Disease
Holding Value $0 0 shares
Last Trade
Oct 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$455k 3,000 shares
$151.80
$10.81
Stock Elyse Director, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Oct 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$118k 775 shares
$151.80
$10.81
Berman Robert Special Projects & Med Ovrsght
Holding Value $33.7k 3,119 shares
Last Trade
Jul 08, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.39M 58,404 shares
$75.25
$10.81
Aguiar Eric Director
Holding Value $15.1k 1,400 shares
Last Trade
Jan 22, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.6k 200 shares
$58.00
$10.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up